The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Celgene; Gilead Sciences; Janssen; Roche; Teva
Consulting or Advisory Role - Celgene; Teva
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Teva
CD68+ tumor-associated myeloid cells as the target of adenosine-induced gene products and predictor of response to adenosine blockade with ciforadenant (cifo) in renal cell cancer (RCC).
 
Martin H Voss
Stock and Other Ownership Interests - CellGenix (I)
Consulting or Advisory Role - Alexion Pharmaceuticals; Calithera Biosciences; Corvus Pharmaceuticals; Eisai; Exelixis; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Genentech/Roche; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Eisai; Takeda
 
Andrew N. Hotson
Employment - Corvus Pharmaceuticals
Stock and Other Ownership Interests - Corvus Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Corvus Pharmaceuticals
 
Stephen Willingham
Employment - Corvus Pharmaceuticals
Stock and Other Ownership Interests - Corvus Pharmaceuticals; Forty Seven
Patents, Royalties, Other Intellectual Property - Corvus Pharmaceuticals; Forty Seven
Travel, Accommodations, Expenses - Corvus Pharmaceuticals
 
Brett Gordon Maxwell Hughes
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; MSD Oncology; Pfizer; Roche; Sanofi/Regeneron
Research Funding - Amgen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb
 
Jaime R. Merchan
Consulting or Advisory Role - Exelixis
Research Funding - Corvus Pharmaceuticals (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Replimune (Inst); Rexahn Pharmaceuticals (Inst); Seattle Genetics/Astellas (Inst); Sillajen (Inst); Tizona Therapeutics, Inc. (Inst); Tizona Therapeutics, Inc. (Inst); Tocagen (Inst); Vyriad (Inst)
 
Lawrence Fong
Consulting or Advisory Role - Atreca; BioAtla; Bolt Biotherapeutics; Nutcracker Therapeutics, Inc.; TeneoBio
Research Funding - Abbvie (Inst); Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Janssen Oncology (Inst); Merck (Inst); Roche/Genentech (Inst)
 
Michael Chu
No Relationships to Disclose
 
Saby George
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Corvus Pharmaceuticals; EMD Serono; Exelixis; Genentech/Roche; Janssen Oncology; Pfizer; Sanofi; Seattle Genetics/Astellas
Research Funding - Agensys (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Corvus Pharmaceuticals (Inst); Eisai (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Seattle Genetics/Astellas (Inst)
 
Brian Munneke
Employment - Corvus Pharmaceuticals
Stock and Other Ownership Interests - Corvus Pharmaceuticals
 
Mehrdad Mobasher
Employment - Corvus Pharmaceuticals; Genentech
Leadership - Corvus Pharmaceuticals
Stock and Other Ownership Interests - Corvus Pharmaceuticals; Roche
Research Funding - Corvus Pharmaceuticals; Genentech
Travel, Accommodations, Expenses - Corvus Pharmaceuticals; Genentech
 
Richard A. Miller
Employment - Corvus Pharmaceuticals; Roche/Genentech (I)
Leadership - Corvus Pharmaceuticals; Genentech/Roche (I)
Stock and Other Ownership Interests - Bolt Biotherapeutics; Corvus Pharmaceuticals; Genentech/Roche (I)
Patents, Royalties, Other Intellectual Property - Inventor on patent application dealing with Corvus product under development